• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性胶质瘤中的表观遗传异常:通往更好理解与治疗的一扇大门。

Epigenetic aberrations in malignant gliomas: an open door leading to better understanding and treatment.

作者信息

Martinez Ramon, Schackert Gabriele

机构信息

Department of Neurosurgery, University of Dresden, Dresden, Germany.

出版信息

Epigenetics. 2007 Jul-Sep;2(3):147-50. doi: 10.4161/epi.2.3.5049. Epub 2007 Sep 15.

DOI:10.4161/epi.2.3.5049
PMID:18063907
Abstract

Malignant gliomas and specially glioblastoma multiforme are the most frequent and devastating brain tumors in adults. Intensive molecular and cytogenetical studies have revealed a wide variety of deregulated genes implicated in cell cycles, DNA repair, apoptosis, cell migration, invasion and angiogenesis with little translational success. An increasing number of reports investigating epigenetic injuries in malignant gliomas have been recently published, although the panorama of CpG island aberrant hypermethylation, histone modification and chromatin states in these lethal tumors is only partially devised. In the present analysis, we discuss the magnitude and significance of epigenetic lesions in the pathogenesis and mechanisms of progression of malignant gliomas as well as their influence on patient survival. The new venue of epigenetic research provides tools for the identification of genes differentially methylated that may be implicated in tumorigenesis and furthermore, epigenetics-based drugs may constitute a promising alternative resource of therapy for this, to the moment, incurable malignancy.

摘要

恶性胶质瘤,特别是多形性胶质母细胞瘤,是成人中最常见且最具破坏性的脑肿瘤。深入的分子和细胞遗传学研究揭示了多种与细胞周期、DNA修复、细胞凋亡、细胞迁移、侵袭及血管生成相关的失调基因,但转化应用方面成效甚微。最近,越来越多关于恶性胶质瘤表观遗传损伤的研究报告发表,尽管这些致命肿瘤中CpG岛异常高甲基化、组蛋白修饰和染色质状态的全貌仅得到部分揭示。在本分析中,我们讨论了表观遗传损伤在恶性胶质瘤发病机制和进展过程中的程度及意义,以及它们对患者生存的影响。表观遗传学研究的新领域为鉴定可能与肿瘤发生相关的差异甲基化基因提供了工具,此外,基于表观遗传学的药物可能成为治疗这种目前无法治愈的恶性肿瘤的一种有前景的替代资源。

相似文献

1
Epigenetic aberrations in malignant gliomas: an open door leading to better understanding and treatment.恶性胶质瘤中的表观遗传异常:通往更好理解与治疗的一扇大门。
Epigenetics. 2007 Jul-Sep;2(3):147-50. doi: 10.4161/epi.2.3.5049. Epub 2007 Sep 15.
2
Glioma epigenetics: From subclassification to novel treatment options.胶质瘤的表观遗传学:从亚分类到新的治疗选择。
Semin Cancer Biol. 2018 Aug;51:50-58. doi: 10.1016/j.semcancer.2017.11.010. Epub 2017 Nov 21.
3
The DNA methylome of glioblastoma multiforme.胶质母细胞瘤的 DNA 甲基组。
Neurobiol Dis. 2010 Jul;39(1):40-6. doi: 10.1016/j.nbd.2009.12.030. Epub 2010 Jan 11.
4
Epigenetics in human gliomas.人类神经胶质瘤中的表观遗传学。
Cancer Lett. 2014 Jan 28;342(2):185-92. doi: 10.1016/j.canlet.2012.04.008. Epub 2012 Apr 21.
5
[Genetic and epigenetic markers of gliomas].[胶质瘤的遗传和表观遗传标志物]
Tsitologiia. 2013;55(5):290-9.
6
Epigenetic modification in gliomas: role of the histone methyltransferase EZH2.胶质瘤中的表观遗传修饰:组蛋白甲基转移酶EZH2的作用
Expert Opin Ther Targets. 2014 Oct;18(10):1197-206. doi: 10.1517/14728222.2014.941807. Epub 2014 Jul 21.
7
Loss of 5hmC identifies a new type of aberrant DNA hypermethylation in glioma.5hmC 的缺失鉴定出胶质瘤中一种新型的异常 DNA 高甲基化。
Hum Mol Genet. 2018 Sep 1;27(17):3046-3059. doi: 10.1093/hmg/ddy214.
8
Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas.位于胶质瘤关键的3p21.3区域内的RASSF1A和BLU基因频繁发生表观遗传失活。
Oncogene. 2004 Mar 25;23(13):2408-19. doi: 10.1038/sj.onc.1207407.
9
Frequent epigenetic inactivation of the SLIT2 gene in gliomas.胶质瘤中SLIT2基因频繁发生表观遗传失活。
Oncogene. 2003 Jul 17;22(29):4611-6. doi: 10.1038/sj.onc.1206687.
10
Global DNA Methylation Patterns in Human Gliomas and Their Interplay with Other Epigenetic Modifications.人类脑胶质瘤中的全球 DNA 甲基化模式及其与其他表观遗传修饰的相互作用。
Int J Mol Sci. 2019 Jul 15;20(14):3478. doi: 10.3390/ijms20143478.

引用本文的文献

1
A Selective Histone Deacetylase Inhibitor Induces Autophagy and Cell Death via SCNN1A Downregulation in Glioblastoma Cells.一种选择性组蛋白去乙酰化酶抑制剂通过下调胶质母细胞瘤细胞中的SCNN1A诱导自噬和细胞死亡。
Cancers (Basel). 2022 Sep 19;14(18):4537. doi: 10.3390/cancers14184537.
2
Targeting CDK9 for the Treatment of Glioblastoma.靶向CDK9治疗胶质母细胞瘤。
Cancers (Basel). 2021 Jun 18;13(12):3039. doi: 10.3390/cancers13123039.
3
Epigenetic Silencing of miR-9 Promotes Migration and Invasion by EZH2 in Glioblastoma Cells.微小RNA-9的表观遗传沉默通过EZH2促进胶质母细胞瘤细胞的迁移和侵袭。
Cancers (Basel). 2020 Jul 3;12(7):1781. doi: 10.3390/cancers12071781.
4
Impact of somatic copy number alterations on the glioblastoma miRNome: miR-4484 is a genomically deleted tumour suppressor.体细胞拷贝数改变对胶质母细胞瘤微小RNA组的影响:miR-4484是一种基因组缺失的肿瘤抑制因子。
Mol Oncol. 2017 Aug;11(8):927-944. doi: 10.1002/1878-0261.12060. Epub 2017 May 24.
5
Gene expression mapping of histone deacetylases and co-factors, and correlation with survival time and 1H-HRMAS metabolomic profile in human gliomas.人类胶质瘤中组蛋白去乙酰化酶及其辅助因子的基因表达图谱,以及与生存时间和1H-HRMAS代谢组学特征的相关性
Sci Rep. 2015 Mar 20;5:9087. doi: 10.1038/srep09087.
6
Inhibitory activities of trichostatin a in U87 glioblastoma cells and tumorsphere-derived cells.三杉酸 A 对 U87 神经胶质瘤细胞和肿瘤球源性细胞的抑制活性。
J Mol Neurosci. 2014 Sep;54(1):27-40. doi: 10.1007/s12031-014-0241-7. Epub 2014 Jan 25.
7
Long noncoding RNA profiles reveal three molecular subtypes in glioma.长链非编码RNA谱揭示了胶质瘤的三种分子亚型。
CNS Neurosci Ther. 2014 Apr;20(4):339-43. doi: 10.1111/cns.12220. Epub 2014 Jan 7.
8
Altered expression of polycomb group genes in glioblastoma multiforme.多梳组基因在多形性胶质母细胞瘤中的表达改变。
PLoS One. 2013 Nov 15;8(11):e80970. doi: 10.1371/journal.pone.0080970. eCollection 2013.
9
DNA methylation in glioblastoma: impact on gene expression and clinical outcome.胶质母细胞瘤中的 DNA 甲基化:对基因表达和临床结局的影响。
BMC Genomics. 2010 Dec 14;11:701. doi: 10.1186/1471-2164-11-701.
10
The evolution and application of techniques in molecular biology to human brain tumors: a 25 year perspective.分子生物学技术在人类脑肿瘤中的发展与应用:25年回顾
J Neurooncol. 2009 May;92(3):261-73. doi: 10.1007/s11060-009-9829-0. Epub 2009 Apr 9.